Global Market Study on Pyrogen Testing: North America Estimated to Be the Dominant Regional Market


  • Published On : Nov-2016 |
  • Pages : 125 Pages |
  • Format :

This report by Persistence Market Research (PMR) examines the ‘Global Pyrogen Testing Market for the period 2016–2024’. The primary objective of the report is to offer updates and information related to the market opportunities in the Global Pyrogen Testing Market.

The global pyrogen testing market report begins with an exhaustive executive summary giving the report data overview and the market taxonomy of the segments covered in the report. It is followed by a market overview that details the dynamics of the global pyrogen testing market, which includes PMR analysis of key trends, drivers, restraints and opportunities that are influencing the growth of the global pyrogen testing market. Impact analysis of the key growth drivers and restraints based on a weighted average model have been included in the global pyrogen testing market report after detailed analysis of individual regions to better equip the readers with meaningful insights on ongoing developments in the market.

Based on test type, the market has been segmented as recombinant factor C assay, monocyte activation assay (MAT), limulus amebocyte lysate test (LAL) and rabbit pyrogen test. A detailed analysis has been provided for these segments in terms of market size, Y-o-Y growth rate, absolute $ opportunity, and BPS analysis.

Based on application, the market is been categorized as injections, vaccines, tablets, medical devices and others. Further, based on end-user segmentation, the market is classified as pharmaceutical industry, biotechnology industry, medical devices industry and others.

The next section of the report analyses pyrogen testing market by region and provides market outlook for 2016-2024. The report also analyses the impact of drivers and restraints in each region. Key regions assessed in this report include North America, Latin America, Europe, Asia Pacific (APAC), and Middle & Africa (MEA).

The above sections – by test type, application, end users, and region – evaluate the present scenario and growth prospects of the global pyrogen testing market for 2016-2024. We have considered 2015 as the base year and provided data for the forecast period, i.e. 2016-2024.

In the final section of the report on the global pyrogen testing market, a ‘Competitive Landscape’ is included to provide report audiences with a dashboard view, based on categories of providers in the global pyrogen testing market product portfolio and key differentiators. Key categories of providers covered in the report are systems, kits and reagents manufacturers. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the pyrogen testing market value chain and the potential players for the same. Report audiences can gain segment-specific vendor insights to identify and evaluate key competitors based on in-depth assessment of capabilities and successes in the global pyrogen testing market.

Detailed profiles of the providers are also included in the scope of the report to evaluate their long- and short-term strategies, key offerings, SWOT analysis, and recent developments in the global pyrogen testing market.

Few of the competitors covered in terms of manufacturers include Charles River Laboratories International, Inc., Lonza Group, Ltd., Merck & Co., Associates of Cape Cod, Inc., ELLAS A/s, GenScript, Wako Chemicals and others.

Research methodology

To ascertain global pyrogen testing market size, we have also considered revenue generated by device manufacturers. The forecast presented here assesses the total revenue across the pyrogen testing market. In order to offer an accurate forecast, we started by sizing up the current market, which forms the basis of how the global pyrogen testing market is expected to develop in the future. Given the characteristics of the market, we triangulated the outcome of three different types of analysis based on supply side, downstream industry demand and the economic envelope. In addition, it is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR, but also analyse it based on key parameters such as year-on-year (Y-o-Y) growth rates to understand the predictability of the market, and to identify the right opportunities across the global pyrogen testing market.

The global pyrogen testing market segments in terms of test type, application, end users, and regions are analysed in terms of Basis Point Share (BPS) to understand individual segment’s relative contributions to market growth. This detailed level of information is important for identifying various key trends in the global pyrogen testing market.

Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective, in the global pyrogen testing market.

To understand key growth segments in terms of growth and adoption for pyrogen testing globally, Persistence Market Research developed the global pyrogen testing market ‘Attractiveness Index’. The resulting index is expected to help providers identify real market opportunities.

Pyrogens are substances that cause fever post administering injection. Increase in body temperature and body ache are the prominent reactions caused due to injection of harmful pyrogens in the body. Pyrogen testing determines the presence of endotoxin substances. The global pyrogen testing market has been segmented on the basis of test type, application, end user, and regions.

The global pyrogen testing market was valued at US$ 538.8 Mn in 2015 and is estimated to be valued at US$ 594.4 Mn by 2016 end. The market is projected to expand at a CAGR of 11.0% during the forecast period in terms of value. Global pyrogen testing market value is expected to increase to US$ 1.37 billion by the end of 2024.

Market dynamics

Growth of the global pyrogen testing market is mainly driven by growing number of pharmaceutical and biotechnology companies globally, increasing research and development investments and rising new drug approvals. In addition, other factors such as rising healthcare expenditure, increasing prevalence of chronic diseases and favorable government initiatives support the market growth. However, high barrier for new entrants is one of the prime factor that restrains the growth of the market over the forecast period. Increasing medical tourism in Asia Pacific and Latin American regions coupled with a growing healthcare industry in emerging economies define the future landscape of the pyrogen testing market.

Segment analysis

Based on test type, the market has been segmented into recombinant factor C assay, limulus amebocyte lysate (LAL), monocyte activation assay (MAT), and rabbit pyrogen test. Limulus amebocyte lysate test is expected to dominate the global pyrogen testing market owing to rising preference for animal-free detection tests coupled with reliable detection of pyrogens support the dominance of this market segment. Rabbit pyrogen test is the oldest commercially available pyrogen testing method. However, rising preference for animal-free detection tests is a prominent factor that restricts uptake of this test type to some extent during the forecast period.

Based on application, the pyrogen testing market is segmented into injections, vaccines, tablets, medical devices and others. Injections and tablets segment are expected to dominate the global pyrogen testing application market over the forecast period.

Based on the end users, the market has been segmented into pharmaceutical industry, biotechnology industry, medical devices industry and others. Other segment includes cosmetic industry, food industry and others where pyrogen testing is utilized for the detection of pathogens. Pharmaceutical industry dominates the pyrogen testing market owing to increasing utilization of pyrogen testing in the pharmaceutical industry coupled with rising number of manufacturers and increasing healthcare awareness.

pyrogen testing market

Regional analysis

The global pyrogen testing market has been segmented into five major regions: North America, Latin America, Europe, Asia Pacific (APAC), and Middle East & Africa (MEA). In terms of value, North America is estimated to be the dominant market for global pyrogen testing market in 2016 owing to majority of the key players based in the region coupled with rising research and development activities and growing health care awareness. The North America pyrogen testing market is expected to expand at a CAGR of 10.8% over the forecast period. Limulus amebocyte lysate test (LAL) test type segment is expected to dominate the North America pyrogen testing market in 2016. The market segment is expected to register a CAGR of 11.3% over the forecast period. Asia Pacific and Latin America are estimated to be the fastest growing markets in terms of CAGR during the forecast period.

Key market players

Some of the key players having presence in the global pyrogen testing market are Charles River Laboratories International, Inc., Lonza Group, Ltd., Merck & Co., Associates of Cape Cod, Inc., Genscript, Wako Chemicals, and others. Companies operating in the global pyrogen testing market are focusing on expanding their product portfolio, owing to substantially high demand for pyrogen testing. Key market players are focusing on expanding their presence in Asian countries to meet the growing demand. Furthermore, increasing government initiatives for healthcare awareness in the region are also supporting growth of the market.

Company Profiles 

  • Thermo Fisher Scientific, Inc.
  • Merck & Co., Inc.
  • Associates of Cape Cod, Inc.
  • Charles River Laboratories International, Inc.
  • GenScript
  • Lonza Group
  • Hyglos GmbH
  • Wako Chemicals USA, Inc.
  • Microcoat Biotechnologie GmbH
  • Others.
Back To Top